Compass Pathways Plc Overview
Is CMPS undervalued? Intrinsic value estimate stands at $1.4.
Get informed when a big investor buys or sells
+ Follow$1.38
Overvalued by 90.7% based on the discounted cash flow analysis.
Compass Pathways Plc (CMPS) currently reports a DCF fair value of $1.4. Use the charts on this page to explore Compass Pathways Plc's DCF fair value history and peer comparisons.
Compass Pathways Plc's discounted cash flow (DCF) fair value estimate is $1.4, about 90.7% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $1.4, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Compass Pathways Plc, and consider following CMPS for alerts when major investors trade the stock.
Compass Pathways Plc is classified in the Healthcare sector. On DCF fair value, it currently shows $1.4. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CMPS with unrelated industries.
